Maternal Smoking Induces Acquired CFTR Dysfunction in Neonatal Rats
To the Editor:
Intact CFTR (cystic fibrosis transmembrane conductance regulator) function is crucial for proper airway, pancreatic, and reproductive tract functions by regulating chloride and bicarbonate transport at the epithelial surface (1) . Cystic fibrosis, an autosomal-recessive genetic disorder, is a consequence of dysfunctional CFTR function and results in defective respiratory host defense, including abnormal mucus, diminished mucociliary clearance, and a propensity for bacterial infections, ultimately leading to bronchiectasis (1) . Even in the absence of genetic CFTR mutations, individuals with smoking-related illnesses such as chronic obstructive pulmonary disease can develop acquired CFTR dysfunction, which is associated with chronic bronchitis, disease severity, and bronchiectasis (2) .
Compelling data indicate that acquired CFTR dysfunction is demonstrable in the nasal epithelium (3), lungs (4) , and even sweat glands (5) of smokers with and without chronic obstructive pulmonary disease compared with healthy control subjects, and can partially (but not completely) reverse with smoking cessation (6) . Elevated sweat chloride levels underscore the fact that cigarette smoking causes systemic CFTR dysfunction beyond the respiratory tract. Moreover, in vitro evidence demonstrates that plasma from smokers can transmit CFTR dysfunction to healthy human bronchial epithelial cells (5) , indicating that reactive constituents such as acrolein (5), cadmium (7) , and other oxidants (1) have the potential to reduce CFTR function.
Maternal smoking confers a risk of infection to the infant, including otitis media, upper respiratory infections, and pneumonia; however, the mechanistic basis of this heightened risk is not well established (8) . The consequences of smoking for the respiratory health of infants have been postulated to be partially induced in utero through transplacental exposure to circulating cigarette smoke toxins during the key stages of neonatal development (8, 9) . However, to our knowledge, there have been no studies investigating the effects of smoking on the epithelial function of the infant or fetus. We hypothesized that cigarette smoking by pregnant mothers could induce acquired CFTR dysfunction and transmit this to the fetus, ultimately inducing a risk of respiratory infection. A portion of this work has been presented in the form of an abstract (10) . Methods Pregnant rodent model. All studies were approved by the University of Alabama at Birmingham Institutional Animal Care and Use Committee (20342). Pregnant Sprague Dawley rats (10 wk old, n = 12) were exposed to mainstream cigarette smoke for 10 days before fertilization and throughout their 21-to 23-day gestation using a whole-body exposure chamber and smoking apparatus (InExpose, SCIREQ). Smoke exposure was applied 4 hours daily, 5 days a week, with an average of 800 mg/L particulate matter per day. Air-exposed pregnant control rats (n = 10) were placed in identical chambers for the same duration. Tracheas were excised from neonates at Day 0 (within 12 h of delivery) and Day 3 of life. There was no ongoing cigarette smoke exposure to neonates postpartum.
CFTR expression and function. CFTR activity was measured ex vivo in excised tracheas from Day 0 and Day 3 neonates using short-circuit current (I sc ) analysis under voltage-clamp conduits as previously described (11) . CFTR mRNA was extracted with the RNeasy Mini Kit (Qiagen). qRT-PCR was performed using the QuantStudio 3 system (Life Technologies) with the TaqMan RNAto-Ct 1-Step Kit and TaqMan gene expression assays (Thermo Scientific) (b-actin and CFTR). PCR amplifications were performed in triplicate and gene expression was determined by the comparative cycle threshold (DDC t ) method using b-actin as an internal control as described previously (4) .
Statistics. Descriptive statistics (mean, SD, and SEM) were compared using Student's t test or ANOVA as appropriate. All statistical tests were two-sided and were performed at a 5% significance level using GraphPad Prism (GraphPad Software Inc.).
Results
Maternal smoking reduced the weight of rat neonates at birth (Day 0) by 14.1% compared with air control neonates (P , 0.0001), consistent with known effects on growth (8) . Reduced weight persisted by 12.5% at Day 3 (P , 0.0001) despite cessation of smoke exposure postpartum ( Figure 1F ).
CFTR function was studied in smoke-exposed and air control neonates at birth via I sc analysis of excised tracheas ( Figures 1A and  1B) . As opposed to postpartum females (32.4 1 36.9 mA/cm 2 ) or historic mixed-sex adult rats (38.9 1 73.4 mA/cm 2 ) (11), neonates had minimal endogenous CFTR preactivation under voltage-clamp conditions, and thus a preserved I sc response to cAMP stimulation, permitting traditional estimates of CFTR activity by forskolin stimulation (followed by CFTR inhibitor response). On Day 0, neonates from smoke-exposed mothers had a mean (6 SEM) CFTR-dependent forskolin-stimulated ΔI sc of 192.3 6 18.9 mA/cm 2 , a 43.6% reduction compared with air control neonates (341.1 6 28.1 mA/cm 2 ; P , 0.001; Figure 1C ). These results were substantiated by a 30.1% reduction in CFTR Inh -172 (selective CFTR inhibitor 172) currents (2192.6 6 23.7 mA/cm 2 smoke vs. 2275.4 6 18.5 mA/cm 2 control; P , 0.01; Figure 1D ). Although there were important trends, maternal smoking did not significantly ; P . 0.05) were significantly different between neonates of smoke-exposed mothers and controls, respectively. As seen in nasal (3) and lung (4) specimens from humans, the relative levels of tracheal CFTR mRNA expression by real-time RT-PCR were significantly reduced in Day 0 smokeexposed neonates (0.5-fold 6 0.04-fold) compared with controls (P , 0.0001; Figure 1E ). Finally, examination of time-dependent changes revealed that the negative effect of maternal smoking on CFTR-dependent I sc dissipated by Day 3 in the absence of ongoing exposure ( Figure 1G ).
Discussion
Systemic acquired CFTR dysfunction is attributable to circulating cigarette toxins in the blood of individuals who smoke (5). Likewise, this has significant ramifications for a developing fetus subjected to maternal smoking in utero, especially given our understanding of the numerous respiratory and infectious sequelae that occur in neonates postpartum (8) . Our study demonstrates that maternal smoking impairs airway CFTR-dependent epithelial ion transport in neonates immediately at birth. There were nonsignificant effects on amiloride-sensitive and ATP-dependent currents, highlighting the specificity of these toxins for the CFTR channel. Furthermore, this significant effect on CFTR dissipated by Day 3 without ongoing smoke exposure postpartum, indicating the potential reversibility of this acquired CFTR dysfunction in neonates with a high regenerative capacity. However, although this scenario is promising and helpful to ascertain causality, it is distinct from reality in that the majority of infants exposed to maternal smoking in utero have continued passive environmental smoke exposure throughout infancy. Compared with adult rats, neonatal rats exhibit a more robust response to forskolin owing to less cAMP preactivation, and understanding the underlying cause of this could reveal new information regarding CFTR regulation.
Emerging data on maternal smoking now underscore the role of epigenetic modifications in fetal respiratory development and neonatal illness (9, 12) . Our data also suggest a mechanistic link for neonatal-acquired CFTR dysfunction in that relative CFTR mRNA levels were reduced in tracheas from smoke-exposed mothers compared with controls. This observation is consistent with literature on genome-wide fetal DNA methylation secondary to maternal smoking (12) . Our study represents the first report of maternal smoking impairing fetal epithelial physiology and may indicate why infants of smokers are predisposed to respiratory disorders. Additionally, given the substantial role of CFTR potentiators in the treatment of cystic fibrosis, our results indicate a potential therapeutic target for CFTR dysfunction in infants of mothers who smoke. n
